EMPLOYMENT AGREEMENTEmployment Agreement • August 1st, 2016 • Sagent Pharmaceuticals, Inc. • Pharmaceutical preparations • Illinois
This EMPLOYMENT AGREEMENT (“Agreement”) is entered into as of the 27th day of June, 2016 (the “Effective Date”), by and between Sagent Pharmaceuticals, Inc., a Delaware corporation (the “Employer” or the “Company”), and Donald Bullock, an individual (the “Executive”).
Sagent Pharmaceuticals, Inc.Sagent Pharmaceuticals, Inc. • August 1st, 2016 • Pharmaceutical preparations
We are pleased to inform you that, on July 10, 2016, Sagent Pharmaceuticals, Inc. (“Sagent”) entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with Shepard Vision, Inc., a Delaware corporation (“Purchaser”) and a direct wholly owned subsidiary of Nichi-Iko Pharmaceutical Co., Ltd., a Japanese corporation (“Parent” or “Nichi-Iko”). In accordance with the Merger Agreement, Purchaser has commenced on August 1, 2016 a tender offer to purchase all of the outstanding shares of common stock of Sagent, $0.01 par value per Share (the “Shares”), at a price of $21.75 per Share (the “Offer Price”), net to the holder in cash, without interest, less any applicable withholding taxes (the “Offer”).
